XML 66 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Retirement-Related Benefits:
9 Months Ended
Sep. 30, 2013
Retirement-Related Benefits:  
Retirement-Related Benefits:

8. Retirement-Related Benefits: The company offers defined benefit pension plans, defined contribution pension plans, as well as nonpension postretirement plans primarily consisting of retiree medical benefits. The following table provides the total retirement-related benefit plans’ impact on income before income taxes:

Yr. to Yr.
(Dollars in millions)Percent
For the three months ended September 30:20132012Change
Retirement-related plans – cost
Defined benefit and contribution pension plans – cost $ 631$ 612 3.1%
Nonpension postretirement plans – cost 74 86 (14.0)
Total$ 705$ 698 1.0%
Yr. to Yr.
(Dollars in millions)Percent
For the nine months ended September 30:20132012Change
Retirement-related plans – cost
Defined benefit and contribution pension plans – cost $ 1,941$ 1,602 21.1%
Nonpension postretirement plans – cost 224 260 (13.6)
Total$ 2,165$ 1,862 16.3%

The following tables provide the components of the cost/(income) for the company’s pension plans:

Cost/(Income) of Pension Plans
(Dollars in millions)U.S. PlansNon-U.S. Plans
For the three months ended September 30:2013201220132012
Service cost$$$ 124$ 109
Interest cost 495 549 379 439
Expected return on plan assets (995) (1,011)(546) (570)
Amortization of prior service costs/(credits) 2 2 (29) (39)
Recognized actuarial losses 448 333 397 255
Curtailments and settlements00
Multi-employer plans/other costs 16 188*
Total net periodic pension (income)/cost of defined
benefit plans (50) (127) 341 381
Cost of defined contribution plans 204 209 137 148
Total defined benefit and contribution plans cost recognized
in the Consolidated Statement of Earnings$ 154$ 82$ 478$ 530

* Includes a $162 million charge related to litigation involving one of IBM UK’s defined benefit plans.

(Dollars in millions)U.S. PlansNon-U.S. Plans
For the nine months ended September 30:2013201220132012
Service cost$$$ 375$ 332
Interest cost 1,485 1,647 1,137 1,332
Expected return on plan assets (2,986) (3,033) (1,636) (1,723)
Amortization of prior service costs/(credits) 7 7(90) (116)
Recognized actuarial losses 1,343 998 1,195770
Curtailments and settlements 1
Multi-employer plan/other costs 71 234*
Total net periodic pension (income)/cost of defined
benefit plans (151) (381) 1,052 831
Cost of defined contribution plans 603 686 437 467
Total defined benefit and contribution plans cost recognized
in the Consolidated Statement of Earnings$ 452$ 305$ 1,489$ 1,297

* Includes a $162 million charge related to litigation involving one of IBM UK’s defined benefit plans.

In 2013, the company expects to contribute to its non-U.S. defined benefit and multi-employer plans approximately $500 million, which will be mainly contributed to the defined benefit pension plans in Japan, the UK and Switzerland. This amount represents the legally mandated minimum contribution. Total net contributions to the non-U.S. plans in the first nine months of 2013 were $397 million.

The following table provides the components of the cost/(income) for the company's nonpension postretirement plans:
Cost of Nonpension Postretirement Plans
U.S. PlanNon-U.S. Plans
(Dollars in millions)2013201220132012
For the three months ended September 30:
Service cost$ 9$ 9$ 2$ 2
Interest cost 41 50 14 16
Expected return on plan assets 0 (2) (2)
Amortization of prior service costs/(credits) (1) (1)
Recognized actuarial losses 5 8 6 4
Total nonpension postretirement plan cost recognized in
Consolidated Statement of Earnings$ 55$ 67$ 19$ 19
(Dollars in millions)U.S. PlanNon-U.S. Plans
For the nine months ended September 30:2013201220132012
Service cost$ 26$ 28$ 7$ 7
Interest cost 123 150 46 48
Expected return on plan assets (1) (7) (7)
Amortization of prior service credits (4) (3)
Recognized actuarial losses 16 24 18 13
Curtailments and settlements 0
Total nonpension postretirement plan cost recognized in
Consolidated Statement of Earnings$ 164$ 201$ 60$ 58

The company received a $8.2 million subsidy in the third quarter of 2013 and a $24.4 million subsidy for the first nine months of 2013 in connection with the Medicare Prescription Drug Improvement and Modernization Act of 2003. A portion of this subsidy is used by the company to reduce its obligation and expense related to the plan, and the remainder is contributed to the plan to reduce contributions required by the participants.